Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
10.20
-0.46 (-4.32%)
Nov 21, 2024, 4:00 PM EST - Market closed
Benitec Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 237 | 65 | 7 | 9 | 33 | 8 | |
| Market Cap Growth | 2012.39% | 881.17% | -29.60% | -71.60% | 294.06% | -94.82% | |
| Enterprise Value | 180 | 52 | 1 | 2 | 22 | -5 | |
| Last Close Price | 10.66 | 6.99 | 4.05 | 19.72 | 72.25 | 134.47 | |
| PS Ratio | - | - | 88.98 | 129.85 | 565.78 | 83.05 | |
| PB Ratio | 2.97 | 1.39 | 33.04 | 3.29 | 1.67 | 0.83 | |
| P/TBV Ratio | 2.53 | 1.39 | 33.04 | 3.29 | 1.67 | 0.83 | |
| EV/Sales Ratio | - | - | 9.94 | 23.51 | 367.04 | - | |
| Debt / Equity Ratio | 0.00 | 0.01 | 2.77 | 0.28 | 0.01 | 0.04 | |
| Asset Turnover | - | - | 0.01 | 0.01 | 0.00 | 0.01 | |
| Quick Ratio | 14.90 | 10.38 | 0.64 | 1.61 | 14.46 | 8.68 | |
| Current Ratio | 15.01 | 10.49 | 0.94 | 1.90 | 15.05 | 9.51 | |
| Return on Equity (ROE) | -48.23% | -91.68% | -1268.61% | -159.08% | -91.79% | -61.67% | |
| Return on Assets (ROA) | -29.23% | -49.60% | -228.53% | -81.59% | -51.55% | -33.58% | |
| Return on Capital (ROIC) | -32.12% | -58.21% | -535.50% | -93.32% | -55.06% | -38.00% | |
| Earnings Yield | -8.64% | -33.22% | -293.13% | -192.08% | -41.59% | -97.67% | |
| FCF Yield | -8.11% | -29.91% | -269.92% | -167.86% | -39.10% | -90.07% | |
| Buyback Yield / Dilution | -250.17% | -192.98% | -188.30% | -90.24% | -320.63% | -19.19% | |
| Total Shareholder Return | -250.17% | -192.98% | -188.30% | -90.24% | -320.63% | -19.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.